#Industry News
Introducing the Randox Stroke Biochip
Rapid, Accurate Stroke Diagnosis & Differentiation
The Randox Stroke Biochip is a rapid and highly sensitive blood test that will complement and enhance existing CT scanning technology to facilitate accurate classification of stroke patients and improve patient care pathways.
Using Randox revolutionary patented Biochips, the Randox Stroke Biochip provides a unique solution for simultaneous detection of multiple stroke biomarkers from a single sample, facilitating fast and accurate classification of stroke patients in an emergency setting.
Benefits of the Randox Stroke Biochip
• Results in 30 minutes on the Evidence MultiSTAT
• Unique solution for stroke classification
• Differentiation of ischaemic and haemorrhagic stroke
• Guarantees rapid thrombolytic therapy ensuring better patient outcomes